Gene: MFSD4B
Official Full Name: major facilitator superfamily domain containing 4Bprovided by HGNC
Gene Summary: Predicted to enable D-glucose transmembrane transporter activity. Predicted to be involved in hexose transmembrane transport and sodium ion transport. Predicted to be located in apical plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23382 | MFSD4B Knockout cell line (HeLa) | Human | MFSD4B | 1:3~1:6 | Negative | Online Inquiry |
KO23383 | MFSD4B Knockout cell line (HCT 116) | Human | MFSD4B | 1:2~1:4 | Negative | Online Inquiry |
KO23384 | MFSD4B Knockout cell line (HEK293) | Human | MFSD4B | 1:3~1:6 | Negative | Online Inquiry |
KO23385 | MFSD4B Knockout cell line (A549) | Human | MFSD4B | 1:3~1:4 | Negative | Online Inquiry |
MFSD4B Gene Knockout Cell Lines are specialized cellular models that have been engineered to lack the expression of the MFSD4B gene, a crucial element in cellular transport mechanisms and metabolic processes. These cell lines are created through advanced gene editing techniques, such as CRISPR-Cas9, allowing researchers to investigate the functional consequences of MFSD4B gene deletion on various biological pathways.
Key functions of MFSD4B involve its role in lipid metabolism and cellular detoxification. By creating knockout models, researchers can elucidate the direct effects of MFSD4B absence on cell behavior, including alterations in membrane composition, metabolic profiling, and response to oxidative stress. The mechanistic insights gained from these studies are vital for understanding the molecular underpinnings and pathological implications of diseases, including metabolic syndromes and certain types of cancer.
The scientific importance of MFSD4B Gene Knockout Cell Lines extends to numerous applications in research settings, particularly in functional genomics and drug discovery. These cell lines serve as invaluable tools for evaluating potential therapeutic compounds, understanding gene-environment interactions, and developing strategies for targeted therapy.
Compared to traditional cell lines, our MFSD4B Gene Knockout models offer distinctive advantages, including a specific focus on gene function that allows for a more precise study of gene-related disease mechanisms. Furthermore, they provide a reliable system for validating genetic hypotheses and screening for pharmacological agents that may interact with the pathways influenced by MFSD4B.
For researchers and clinicians, the availability of MFSD4B Gene Knockout Cell Lines presents an opportunity to advance knowledge in the field of molecular biology and therapeutics. Our commitment to quality and innovation ensures that each cell line is rigorously validated for performance and reliability, making them an essential asset in your research toolkit. With extensive experience in delivering high-quality biological products, our company remains dedicated to supporting the scientific community in unlocking new discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.